Why AlphaFold 3 is stirring up so much buzz in pharma

The artificial intelligence program AlphaFold 3, rolled out by Google DeepMind and Isomorphic Labs earlier this month, has been called “groundbreaking,” holding transformative potential in drug discovery.

The hype is warranted, said Patrick Bangert, senior vice president of data, analytics, and AI at Searce, a cloud services company.